BACKGROUND: Elevated estimated blood viscosity (EBV), derived from hematocrit and
globulins, is associated with thrombotic complications, organ failure, and higher mortality in …

Abstract Background Coronavirus disease-2019 (COVID-19) is characterized by a
dysfunctional immune response and abnormal blood rheology that contribute to endothelial …

Background Increased estimated whole blood viscosity (eWBV) predicts higher mortality in
patients hospitalized for coronavirus disease 2019 (COVID-19). This study assesses …

Although COVID-19 begins as a respiratory pneumonia, we are now discovering it causes
an intense inflammatory response accompanied by systemic microangiopathy. In reflecting …

Background Recent data suggests an association between blood hyperviscosity and both
propensity for thrombosis and disease severity in patients with COVID‐19. This raises the …

COVID-19 is the important global problem. This new coronavirus can cause several
hematological changes. Thrombosis is a problem might occur in COVID-19. In COVID-19 …

The aim of this study was to (1) analyze blood viscosity, red blood cell (RBC) deformability,
and aggregation in hospitalized patients with Coronavirus disease 19 (COVID‐19);(2) test …

Coronavirus disease 2019 (COVID-19) is caused by a novel virus known as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2-induced …

Many of the complications of severe coronavirus disease-2019 (COVID-19) are caused by
blood hyperviscosity driven by marked hyperfibrinogenemia. This results in a distinctive …

Abstract Keywords: COVID-19; red blood cell; deformability; aggregation; blood viscosity EN
COVID-19 red blood cell deformability aggregation blood viscosity e108 e111 4 02/17/21 …